YTHDF2 and melanoma: This interaction also impacts the cytotoxic response of NK‐92MI cells against HCC cells, suggesting that targeting LINC00707‐YTHDF2 interactions could provide therapeutic benefits in HCC.[155] Similarly, increased JPX lncRNA expression exacerbates disease progression by interacting with YTHDF2 in melanoma.